The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

A De Luca, MR Maiello, A D'Alessio… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: The RAS/RAF/MAP kinase–ERK kinase (MEK)/extracellular-signal-regulated
kinase (ERK)(MAPK) and the PI3K/AKT/mammalian target of rapamycin (mTOR)(PI3K) …

Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

K Nosho, Y Baba, N Tanaka, K Shima… - The Journal of …, 2010 - Wiley Online Library
The abundance of tumour‐infiltrating T‐cells has been associated with microsatellite
instability (MSI) and a favourable prognosis in colorectal cancer. However, numerous …

The PI3K/Akt/mTOR axis in colorectal cancer: oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles

MJ Sanaei… - Journal of Cellular …, 2022 - Wiley Online Library
Colorectal cancer (CRC) is one of the deadliest human malignancies worldwide. Several
molecular pathways have been demonstrated to be involved in the initiation and …

PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup

L Wang, H Hu, Y Pan, R Wang, Y Li, L Shen, Y Yu, H Li… - PloS one, 2014 - journals.plos.org
Purpose PIK3CA gene encoding a catalytic subunit of the phosphatidylinositol-3-kinase
(PI3K) is mutated and/or amplified in various neoplasia, including lung cancer. Here we …

PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival

C Rosty, JP Young, MD Walsh, M Clendenning… - PloS one, 2013 - journals.plos.org
Mutations in PIK3CA are present in 10 to 15% of colorectal carcinomas. We aimed to
examine how PIK3CA mutations relate to other molecular alterations in colorectal …

A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy

V Deschoolmeester, M Baay, P Specenier… - The …, 2010 - academic.oup.com
Rapidly growing insights into the molecular biology of colorectal cancer (CRC) and recent
developments in gene sequencing and molecular diagnostics have led to high expectations …

PIK3CA gene mutations in solid malignancies: association with clinicopathological parameters and prognosis

A Alqahtani, HSK Ayesh, H Halawani - Cancers, 2019 - mdpi.com
Phosphoinositide kinases (PIKs) are a group of lipid kinases that are important upstream
activators of various significant signaling pathways. Hyperactivation of the PI3K/AKT/mTOR …

[HTML][HTML] Biomarkers in colorectal cancer: Current clinical utility and future perspectives

M Vacante, AM Borzì, F Basile… - World journal of clinical …, 2018 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is a major cause of cancer death worldwide. CRC has poor
prognosis and there is a crucial need for new diagnostic and prognostic biomarkers to avoid …

Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology

S Ogino, P Lochhead, E Giovannucci, JA Meyerhardt… - Oncogene, 2014 - nature.com
Regular use of aspirin reduces incidence and mortality of various cancers, including
colorectal cancer. Anticancer effect of aspirin represents one of the 'Provocative Questions' …

Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials

X Li, D Dai, B Chen, H Tang, X Xie, W Wei - PloS one, 2018 - journals.plos.org
Background The phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin
(mTOR) pathway (PI3K/AKT/mTOR pathway) plays a key role in cancer. We performed this …